LarryLKestinMDFACR, FASTRO

Gastrointestinal Cancer, Sarcoma, Thoracic Cancer, Urologic Cancer

Medical Director, MHP Radiation Oncology Institute; Clinical Professor, Wayne State University

Dr. Kestin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
28595 Orchard Lake Rd
Suite 110
Farmington Hills, MI 48334
Phone+1 248-553-0606

Fax+1 248-553-7674

Larry L. Kestin, MD, FACR, FASTRO has authored over 400 peer-reviewed journal publications, abstracts and book chapters. He is a radiation oncology written and oral boards examiner for the American Board of Radiology and Chair of the Lung/Sarcoma section. He is a member of the NCI Thoracic Malignancy Steering Committee and has been a member of multiple ASTRO Committees. He has held academic appointments as a full professor at Oakland University and UCLA and was Program Director for the Department of Radiation Oncology at William Beaumont Hospital. Dr. Kestin is also a Clinical Professor at Wayne State University. He is actively involved in clinical research and has served as Principal Investigator for many local as well as national clinical trials

Corewell Health East Beaumont (Royal Oak)Residency, Radiation Oncology, 1995 - 2000
University of Kansas School of MedicineClass of 1995
University of Missouri-ColumbiaBS, Computer Science, 1986 - 1991

PubMed

7 citations
Chemoradiation with Hypofractionated Proton Therapy in Stage II-III Non-Small Cell Lung Cancer: A Proton Collaborative Group Phase 2 Trial.
Bradford S Hoppe, Romaine C Nichols, Stella Flampouri, Mark Pankuch, Christopher G Morris
International Journal of Radiation Oncology, Biology, Physics. 2022-07-15
187 citations
Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.
Carlos Vargas, Alvaro Martinez, Larry L. Kestin, Di Yan, Inga S. Grills
International Journal of Radiation Oncology, Biology, Physics. 2005-08-01
77 citations
Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
Carlos Vargas, Di Yan, Larry L. Kestin, Daniel J. Krauss, David Lockman
International Journal of Radiation Oncology, Biology, Physics. 2005-09-01

Optimizing Nutritional Support in the Critically Ill: Evaluation of a Dedicated Team Approach to Placement of Nasojejunal Feeding TubesAugust 28th, 2024
Dr. Larry Kestin, 21st Century Oncology's Medical Director, Michigan Region, Named A Fellow of the American Society for Radiation and Oncology (ASTRO)October 2nd, 2019